Gossamer Bio, Inc. (GOSS) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $79.0K | — |
| 2024 | $0 | — |
| 2023 | $0 | -100.0% |
| 2022 | $410.0K | -73.5% |
| 2021 | $1.55M | +2.9% |
| 2020 | $1.50M | -49.3% |
| 2019 | $2.97M | -15.0% |
| 2018 | $3.49M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $79.0K | — |
| 2024 | $0 | — |
| 2023 | $0 | -100.0% |
| 2022 | $410.0K | -73.5% |
| 2021 | $1.55M | +2.9% |
| 2020 | $1.50M | -49.3% |
| 2019 | $2.97M | -15.0% |
| 2018 | $3.49M | — |